BIOFARMA Srl

3D MAXX Patch for Atopic Skin

Designed to treat atopic skin, this patch is composed of a biomimetic nanofibrous matrix of hyaluronic acid and pullulan, a combination that mimics the skin’s own extracellular matrix to soothe, hydrate, and restore the skin barrier. An alternative to creams or hydrogel patches, the patch forms a 200 nm biomimetic scaffold that, as it replicates the skin’s extracellular matrix, enhances skin adhesion, absorption of the active ingredients, and barrier recovery. The patches’ innovation lies in transforming hyaluronic acid and pullulan into a new delivery treatment platform for sensitive skin. Among the patches’ ingredients are pullulan; hydrolyzed hyaluronic acid; niacinamide; hydrogenated lecithin; and ceramide EOP. In clinical trials, the patches reduced the skin condition erythema by 13% after one hour of use, while the scoring of eczema reduced by 8.9 points after 14 days of use, and by 12.5 points after 28 days of use.

Hall (Pavilion) and Stand Number: Hall 15- Stand D6-E5

Image
Product Description (No Prototypes accepted)
Designed to treat atopic skin, this patch is composed of a biomimetic nanofibrous matrix of hyaluronic acid and pullulan, a combination that mimics the skin’s own extracellular matrix to soothe, hydrate, and restore the skin barrier. An alternative to creams or hydrogel patches, the patch forms a 200 nm biomimetic scaffold that, as it replicates the skin’s extracellular matrix, enhances skin adhesion, absorption of the active ingredients, and barrier recovery. The patches’ innovation lies in transforming hyaluronic acid and pullulan into a new delivery treatment platform for sensitive skin. Among the patches’ ingredients are pullulan; hydrolyzed hyaluronic acid; niacinamide; hydrogenated lecithin; and ceramide EOP. In clinical trials, the patches reduced the skin condition erythema by 13% after one hour of use, while the scoring of eczema reduced by 8.9 points after 14 days of use, and by 12.5 points after 28 days of use.
Launch Worldwide Date (First worldwide launch must have been launched within 12 months prior to the event). Date (Month/Day/Year)
03/26/2026
Product Innovation
3D MAXX introduces electrospun nanofiber technology into atopic skincare. Unlike traditional creams or hydrogel patches, it forms a 200 nm biomimetic scaffold that replicates the skin’s extracellular matrix, enhancing adhesion, absorption, and barrier recovery. Fully absorbable and non-occlusive, it enables high active concentration without preservatives. Clinical studies show rapid erythema reduction and significant SCORAD improvement. The innovation lies in transforming structural biomaterials (hyaluronic acid and pullulan) into a functional therapeutic-like dermocosmetic delivery platform, redefining how sensitive and compromised skin receives treatment.
Claims & Benefits
• Deep, long-lasting hydration • Strengthened skin barrier function • Visible immediate lifting and tightening effect • Non-occlusive, breathable second-skin feel • Controlled and targeted active release • Suitable for sensitive and compromised skin • Preservative-free, solvent-free formulation • Fully absorbable • Waterless, lightweight, travel-friendly format • Sustainable, biodegradable bio-based materials
Research, Clinical Tests & Trials Results (Safety & Dermatological)

Atopic-Prone Skin Study
20 volunteers, 4 weeks, daily application, dermatologist supervised.
Instrumental evaluation (Mexameter, SCORAD index).
Top results:
•    -13% erythema after 1 hour
•    SCORAD reduction: -8.9 points (14 days); -12.5 points (28 days)
•    Statistically significant improvement of atopic symptoms

Certifications, Patents & Regulatory Compliance
Patents • Patented electrospinning process for cosmetic nanofiber matrices Certifications (Company Level) • ISO-certified manufacturing facilities • ISO-8 clean room production environment Regulatory Compliance • EU Cosmetics Regulation (EC) No. 1223/2009 • U.S. FDA – MoCRA compliance • China NMPA cosmetic regulation • Brazil ANVISA cosmetic regulation • Japan PMD Act (cosmetics framework) • GMP-compliant manufacturing standards
Ingredients List & Formulation (Mandatory, if not specified disqualification from the contest)
Pullulan Hydrolyzed Hyaluronic Acid Niacinamide Hydrogenated Lecithin Ceramide EOP Sodium surfactin
Technology Features
• Patented electrospinning nanotechnology (~200 nm fibers) • Biomimetic ECM-inspired 3D scaffold • Fully absorbable delivery system • Controlled porosity for targeted release • Non-occlusive breathable structure • Waterless, preservative-free production • Room-temperature manufacturing (energy efficient) • Dual protective substrate layers for stability • Ultra-lightweight format reducing logistics footprint • Precision dosing – single-use application • High surface-to-volume ratio for enhanced bioavailability • Modular platform adaptable to cosmetic, dermocosmetic, and aesthetic needs
Sustainability List of Certifications
N/A
How to use it
• Cleanse skin thoroughly • Lightly mist the target area with water • Remove first protective substrate • Apply patch (matrix side down) • Press gently for a few seconds • Allow matrix to dissolve (few seconds) • Remove second substrate layer • No rinsing required • Follow with usual skincare routine • Use once or twice daily depending on treatment protocol
Website and/or Social Media Channels + Editorial pitch
Editorial Pitch (max 20 words): 3D MAXX: The new era of beauty Website & Social Channels: Website: www.biofarmagroup.com LinkedIn: Biofarma Group Instagram: @biofarmagroup
Packaging Materials
Dual protective substrate layers (polymeric support films) Ultra-thin electrospun active matrix Individual hygienic triple-layer sachet

Timeline

29 October 2025

Platform Opening

11 February 2026

Deadline to purchase contest participation

13 February 2026

Entries closing

12 March 2026

Finalists Announcement

23 March 2026

Deadline for Receiving Products

27 March 2026

Awards Ceremony
Winners Announcement